Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 650.80
-1.30 (-0.20%)
At close: Apr 16, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 161.59 billion as of April 16, 2026. Its market cap has increased by 31.14% in one year.
Market Cap
161.59B
Enterprise Value
173.47B
Revenue
50.92B
Ranking
n/a
PE Ratio
29.00
Stock Price
650.80
Market Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 161.59B, an increase of 98,610.01%. That is a compound annual growth rate of 34.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 161.59B | 11.25% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pharmaceuticals | 407.63B |
| J. B. Chemicals & Pharmaceuticals | 317.59B |
| AstraZeneca Pharma India | 214.18B |
| Jubilant Pharmova | 143.45B |
| Rubicon Research | 135.31B |
| Caplin Point Laboratories | 132.15B |
| CORONA Remedies | 96.76B |
| Viyash Scientific | 91.70B |